NeuroMET mini symposium July 2017
13 Oct 2017
The first NeuroMET mini symposium was held at RI.SE, Göteborg, Sweden, as a satellite event to the Consortium meeting on July 3, 2017. It was attended by Consortium members and stakeholders from clinical laboratories, industry and academia.
Following a brief introduction to NeuroMET
, the symposium included sessions on MRI, cognition and biomarkers, and prompted much discussion between the participants.
Find more details of the presentations below, along with a summary of the project.
Looking back in time: tracing individual brain atrophy in a single time-point MR image
- Rolf Heckemann, MedTechWest, Göteborg
MR Spectroscopy: What is it and what is its importance in AD early diagnosis
- Ariane Fillmer, Physikalisch-Technische Bundesanstalt, Berlin
Towards a Metrology of Cognition
- Stefan Cano, Modus Outcomes
Measuring outcomes in Parkinson's disease: The case of the Unified Parkinson's Disease Rating Scale (UPDRS)
- Peter Hagell, School of Health & Society, Kristianstad University
Gothenburg MCI and dementia studies
- Anders Wallin, MD, Professor of Psychiatry and Neurochemistry, Sahlgrenska Academy
Biomarkers in NeuroMet including immunoassays, PCR and reference methods
- Milena Quaglia, LGC
& Carla Divieto, INRIM
Participants of the first NeuroMET mini-symposium